We also found a higher risk of being diagnosed with pneumonia in patients treated with a combination of insulin, statins and DPP-IV inhibitors and undergoing combination therapy with sulfonylurea and metformin, demonstrating that insulin and insulin-secreting oral antidiabetic drugs seem to compound the development of pneumonia. The gene discussed is INS; the disease is susceptibility to pneumonia measurement.